Correlation Between Duopharma Biotech and Hartalega Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Duopharma Biotech and Hartalega Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Duopharma Biotech and Hartalega Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Duopharma Biotech Bhd and Hartalega Holdings Bhd, you can compare the effects of market volatilities on Duopharma Biotech and Hartalega Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Duopharma Biotech with a short position of Hartalega Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Duopharma Biotech and Hartalega Holdings.

Diversification Opportunities for Duopharma Biotech and Hartalega Holdings

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Duopharma and Hartalega is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Duopharma Biotech Bhd and Hartalega Holdings Bhd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hartalega Holdings Bhd and Duopharma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Duopharma Biotech Bhd are associated (or correlated) with Hartalega Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hartalega Holdings Bhd has no effect on the direction of Duopharma Biotech i.e., Duopharma Biotech and Hartalega Holdings go up and down completely randomly.

Pair Corralation between Duopharma Biotech and Hartalega Holdings

Assuming the 90 days trading horizon Duopharma Biotech is expected to generate 7.83 times less return on investment than Hartalega Holdings. But when comparing it to its historical volatility, Duopharma Biotech Bhd is 1.59 times less risky than Hartalega Holdings. It trades about 0.07 of its potential returns per unit of risk. Hartalega Holdings Bhd is currently generating about 0.35 of returns per unit of risk over similar time horizon. If you would invest  331.00  in Hartalega Holdings Bhd on September 13, 2024 and sell it today you would earn a total of  47.00  from holding Hartalega Holdings Bhd or generate 14.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Duopharma Biotech Bhd  vs.  Hartalega Holdings Bhd

 Performance 
       Timeline  
Duopharma Biotech Bhd 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Duopharma Biotech Bhd are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Duopharma Biotech may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Hartalega Holdings Bhd 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Hartalega Holdings Bhd are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Hartalega Holdings disclosed solid returns over the last few months and may actually be approaching a breakup point.

Duopharma Biotech and Hartalega Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Duopharma Biotech and Hartalega Holdings

The main advantage of trading using opposite Duopharma Biotech and Hartalega Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Duopharma Biotech position performs unexpectedly, Hartalega Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hartalega Holdings will offset losses from the drop in Hartalega Holdings' long position.
The idea behind Duopharma Biotech Bhd and Hartalega Holdings Bhd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital